Bank of Maharashtra profit rises 23%; auditors flag governance and COVID reserve

Emphasis Of MatterRevenue Growth 20pctResults RestatedExceptional ItemResults View source PDF Explain this filing

MAHABANK · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.6%Reaction day

₹57.70

prior close

₹56.08

announcement price

In-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-0.7%-2.9% vs market

Public Sector Bank peers, median of 11sector-2.1%-1.5% vs sector

On the reaction day the stock moved 2.9 pts less than Nifty Midcap 150 and 1.5 pts less than its Public Sector Bank peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.1

10m

-2.2

15m

-2.2

30m

-0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.6-0.7-2.9-2.1-1.5

Next day

+2.6+0.2+2.4+0.1+2.5

+0.1+0.7-0.6-0.7+0.7

-1.0+0.2-1.2-2.2+1.2

+3.2+0.8+2.4+1.3+1.9

+3.8+1.0+2.8+2.1+1.8

+1.9+0.7+1.3+1.3+0.6

15d

-0.4+0.8-1.2+6.8-7.2

+0.5+2.7-2.2+6.9-6.4

-0.6+1.8-2.3+1.8-2.4

+13.9+1.0+12.9+10.0+3.9

UpDownMarket · Nifty Midcap 150Sector · Public Sector Bank peers, median of 11Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Bank of Maharashtra's standalone profit for the September 2025 quarter rose 23.0% to Rs 1,633.14 crore. For April to September 2025, consolidated revenue rose 21.8% to Rs 26,720.19 crore and profit after tax rose 20.7% to Rs 3,172.98 crore. Auditors gave an unmodified review but flagged too few independent directors, an audit committee quorum issue and a Rs 1,200 crore COVID-19 reserve. An extraordinary item of Rs 35.11 crore was booked.

Likely market impact

Profit and revenue growth may support the stock, but governance concerns and the retained COVID-19 reserve may limit investor enthusiasm.